AXSM Axsome Therapeutics, Inc.

HealthcareBiotechnology
$220.22
▼ 1.08%
41
QScore Signal
Short
Confidence: MEDIUM
Long-Term
27
Short-Term
54

Value

4
P/E-59.88
8
P/B206.55
0
P/S16.00
0
EV/EBITDA-65.10
5

Growth

66
Revenue Growth65.5%
100
EPS Growth38.6%
46
FCF Growth27.0%
47

Momentum

91
12-Month Return96.3%
100
3-Month Return21.8%
95
1-Month Return27.2%
100
RSI (14)73.32
82
50/200 MABullish
75

Profitability

12
ROE-260.0%
1
ROA-26.4%
0
Gross Margin92.6%
74
Operating Margin-24.8%
0
Net Margin-26.6%
0
FCF Yield-0.6%
8

Risk

25
Beta0.58
55
60-Day Volatility43.6%
0

Generated 5/7/2026, 10:44:07 PM · How is this calculated?

QScore Analysis